Articles By Alyson Martin

New York

Cannabis Loyalty Programs, Discounts Could Soon Come to New York’s Legal Shops

Regulators proposed new rules to open the door to billboards, discounts, and loyalty programs – which have already shown up at some shops.

New York

New York Cannabis Regulators Intro New Interim Director, Approve Home Grow Rules

Tuesday’s meeting of regulators was the first since Chris Alexander resigned as executive director of the Office of Cannabis Management.

Congress, Hemp

House Ag Committee Votes to “Close the Loophole” on Intoxicating Hemp During Farm Bill Markup 

Committee members who opposed the amendment argued that a ban on hemp-derived products would lead to job loss.

New York

New York Gov. Hochul Announces Cannabis Regulatory “Overhaul,” Says Top Cannabis Regulator Will Depart

A report released Friday following a Hochul-ordered review of the Office of Cannabis Management found a “lack of transparency” and “chaotic” processes.

Congress

Schumer Reintroduces Comprehensive Cannabis Legalization Bill in Congress

Senate Majority Leader Chuck Schumer and Sens. Ron Wyden and Cory Booker are calling for “sensible regulation to take root.”

Regulation

In Historic Move, DEA Will Recommend Cannabis Reclassification

The rescheduling of cannabis, once complete, will mark an historic shift in U.S. cannabis policy, and is likely to send ripple effects across the globe.

New York

Coming to New York Shops and Bodegas that Sell Unregulated Cannabis: Padlocks

Gov. Kathy Hochul came out swinging on Friday against the state’s unregulated cannabis market. Meanwhile, a fund to lift up licensed growers didn’t make the budget.

Regulation

OSHA Officials Lay Out Cannabis Workplace Safety Landscape 

Even though cannabis remains federally illegal, that hasn’t stopped OSHA officials from collecting data on potential workplace safety hazards in the nascent industry.

Regulation

House Lawmakers Push Top FDA Official on Hemp Products and Cannabis Rescheduling 

The conversation covered the proliferation of intoxicating hemp products, as well as the timeline for the federal review of whether to move cannabis from Schedule I to III.